Alcanza Clinical Research

Alcanza Clinical Research operates an integrated network of over twenty dedicated research units and additional embedded sites within specialty clinics across the United States. The company specializes in providing inclusive access to clinical trials for diverse and underrepresented patient populations. It supports studies in all major therapeutic areas and trial phases for pharmaceutical sponsors and CROs. Recent growth has been driven by acquisitions—including Accel Research Site Network and Innovation Medical Research Center—expanding both geographic reach and therapeutic expertise. Alcanza does not develop its own drugs but enables the execution of sponsor-driven clinical programs.